SCHEMBL7809011

SCHEMBL7809011

Cc1ccc(S(=O)(=O)OCCOC(C)COS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 4/20 0.45
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
STAT3 P40763 1/20 0.38
ALDH1A1 P00352 5/20 0.37
GAA P10253 2/20 0.37
GBA1 P04062 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
DHODH Q02127 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CA2 P00918 3/20 0.36
VDR P11473 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
CA7 P43166 2/20 0.35
CA3 P07451 1/20 0.35
CA6 P23280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23160909 1.00 CA9 (0.45) CA9CA12CA1STAT3ALDH1A1
SCHEMBL25532862 0.92 CA9 (0.44) CA9CA12CA1STAT3ALDH1A1
SCHEMBL25532882 0.92 CA9 (0.44) CA9CA12CA1STAT3ALDH1A1
SCHEMBL14827580 0.91 CA9 (0.43) CA9CA12CA1STAT3ALDH1A1
SCHEMBL13309556 0.90 CA12 (0.43) CA9CA12CA1STAT3ALDH1A1
SCHEMBL9261226 0.89 CA12 (0.41) CA9CA12CA1STAT3ALDH1A1
SCHEMBL21114482 0.88 CA12 (0.38) CA9CA12CA1STAT3ALDH1A1
SCHEMBL28973322 0.87 ALDH1A1 (0.39) CA9CA12CA1STAT3ALDH1A1
SCHEMBL28973320 0.87 ALDH1A1 (0.39) CA9CA12CA1STAT3ALDH1A1
SCHEMBL9723867 0.87 CA12 (0.40) CA9CA12CA1STAT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104409-A1 MULTIMERIC MANGANESE CONTRAST AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2026-05-21 WO disclosed
EP-4741400-A1 MULTIMERIC MANGANESE CONTRAST AGENTS Bayer Aktiengesellschaft (DE) 2026-05-13 EP disclosed
US-20210101902-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS NOVARTIS AG (CH) 2021-04-08 US disclosed
US-10954233-B2 Compounds and compositions as inhibitors of endosomal toll-like receptors NOVARTIS AG (CH) 2021-03-23 US disclosed
US-20190211009-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC. 2019-07-11 US disclosed
EP-0787127-B1 5-LIPOXYGENASE INHIBITORS PFIZER (US) 2001-01-03 EP disclosed
US-6063928-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, CARDIOTONIC AGENTS PFIZER INC (US) 2000-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210101902-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS TLR3, TLR1, TLR4 CA9 4137/4885CA12 4716/4885CA1 4465/4885
US-20190211009-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS TLR3, TLR1, TLR4 CA9 4137/4885CA12 4716/4885CA1 4465/4885
US-10954233-B2 Compounds and compositions as inhibitors of endosomal toll-like receptors TLR3, TLR1, TLR4 CA9 4137/4885CA12 4716/4885CA1 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.